Recombinant interleukin-1 promotes leishmaniasis in susceptible mice

Microbiology and Immunology

Volumn 41, Issue 3, 1997, Pages 281-283

  Ajdary, Soheila ^a   Hosseini, Mohammad Hossein ^a   Alimohammadian, Mohammad Hossein ^a  

^a PASTEUR INSTITUTE OF IRAN   (Iran)

Author keywords

BALB c; IL 1; Leishmaniasis

Indexed keywords

INDOMETACIN; PROSTAGLANDIN E2; RECOMBINANT INTERLEUKIN 1;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DISEASE COURSE; FOOT PAD; INFECTION SENSITIVITY; LEISHMANIA MAJOR; LEISHMANIASIS; MACROPHAGE; MOUSE; NONHUMAN; PAW EDEMA; PROMASTIGOTE; PROSTAGLANDIN SYNTHESIS; THICKNESS;

EID: 0030978611     PISSN: 03855600     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1348-0421.1997.tb01202.x     Document Type: Article

References (14)

1. Cillari, E., Dieli, M., Maltese, E., Milano, S., Salerno, A., and Leiw, F.Y. 1989. Enhancement of macrophage IL-1 production by Leishmania major infection in vitro and its inhibition by IFN-gamma. J. Immunol. 143: 2001-2005.
2. Cillari, E., Liew, F.Y., and Lelchuk, R. 1986. Suppression of interleukin-2 production by macrophages in susceptible BALB/c mice infected with Leishmania major. Infect. Immun. 54: 386-394.
3. Doherty, T.M., and Coffman, R.L. 1993. Leishmania antigens presented by GM-CSF-derived macrophages protect susceptible mice against challenge with Leishmania major. J. Immunol. 150: 5476-5483.
4. Farell, J.P., and Kirkpatrick, C.E. 1987. Experimental cutaneous leishmaniasis. II. A possible role for prostaglandins in exacerbation of disease in Leishmania major-infected BALB/c mice. J. Immunol. 138: 902-907.
5. Fith, F.W., Mckistic, M.D., Lanchi, D.W., and Gajewski, T.I. 1993. Differential regulation of mouse T lymphocyte subsets. Annu. Rev. Immunol. 11: 29-48.
6. Gajewski, T.F., Pinns, M., Wong, T., and Fitch, F.W. 1991. Murine Th1 and Th-2 clones proliferate optimally in response to distinct antigen-presenting cell population. J. Immunol. 146: 1750-1758.
7. + T cells. Differential effects of IL-1 on helper and inflammatory T cells. J. Immunol. 140: 1555-1560.
8. + lymphocytes in vivo during healing and progressive murine leishmaniasis. Proc. Natl. Acad. Sci. U.S.A. 88: 7011-7015.
9. Otter, M., Wax, J.S., Anderson, A.O., and Nordan, R.P. 1985. Inhibition of plasmacytoma development in BALB/c mice by indomethacin. J. Exp. Med. 161: 996-1012.
10. Reiner, N.E., and Malemud, C.J. 1984. Arachidonic acid metabolism in murine leishmaniasis (Donovani): ex vivo evidence for increased cyclooxygenase and 5-lipoxygenase activity in spleen cells. Cell. Immunol. 88: 501-510.
11. Scott, P., Natovitz, P., Coffman, R.L., Pearce, E., and Sher, A. 1988. Immunoregulation of cutaneous leishmaniasis. T cell lines that transfer protective immunity or exacerbation belong to different T helper subsets and respond to distinct parasite antigens. J. Exp. Med. 168: 1675-1684.
12. Sher, A., and Coffman, R.I. 1992. Regulation of immunity to parasites by T cells and T cell derived cytokines. Annu. Rev. Immunol. 10: 385-410.
13. Tapia, F.J., Caceres-Dittermax, G., and Sanches, M.A. 1994. Inadequate epidermal homing leads to tissue damage in human cutaneous leishmaniasis. Immunol. Today 15: 160-164.
14. Weaver, C.T., and Unanue, E.R. 1990. The costimulatory function of antigen presenting cells. Immunol. Today 11: 49-55.